Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease-Reference-Cited by-同舟云学术

Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease

Published:2018-02 Issue: Volume:150 Page:217-225
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Li Zhong,Sakamuru Srilatha,Huang Ruili,Brecher Matthew^ORCID,Koetzner Cheri A.,Zhang Jing,Chen Haiying,Qin Cheng-feng,Zhang Qing-Yu,Zhou Jia^ORCID,Kramer Laura D.^ORCID,Xia Menghang,Li Hongmin^ORCID

Funder

NIH

NSFC Excellent Young Scientist

Innovative Research Group

National Key Research and Development Project of China

National Science and Technology Major Project of China

UK Academy of Medical Sciences

NSFC of China

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference45 articles.

1. Scientific Opinion on the re-evaluation of Erythrosine (E 127) as a food additive;(ANS), E.P.o.F.A.a.N.S.a.t.F;EFSA J.,2011

2. ZIKA virus circulates in new regions;Attar;Nat. Rev. Microbiol.,2016

3. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease;Bera;J. Biol. Chem.,2007

4. Anticipating the international spread of Zika virus from Brazil;Bogoch;Lancet,2016

5. Novel broad spectrum inhibitors targeting the flavivirus methyltransferase;Brecher;PLos One,2015

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition;Molecules;2024-08-27

2. An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease;Viruses;2024-08-01

3. Green spectrophotometric and spectrofluorimetric determination of biperiden hydrochloride using erythrosine B sensing probe;Luminescence;2024-03-26

4. Is JEV the New Emerging Encephalitis?;Emerging Human Viral Diseases, Volume II;2024

5. Exploring the viral protease inhibitor space driven by consensus scoring-based virtual screening;In Silico Pharmacology;2023-12-02